Comparison of a Speech-Language Assessment Tool for Pragmatic and Discourse Skills in Schizophrenia Spectrum Disorders
VEOS
1 other identifier
interventional
30
1 country
1
Brief Summary
The scientific literature has largely objectified language disorders in schizophrenia. And more precisely, the impairment of pragmatic and discursive language skills. Currently, there is no standardized language assessment tool specific to these patients. The aim of this study is to compare the effectiveness of a newly developed speech-language assessment tool for pragmatic and discourse skills for patients suffering from schizophrenia .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2023
CompletedFirst Posted
Study publicly available on registry
February 24, 2023
CompletedStudy Start
First participant enrolled
March 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 6, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 13, 2024
CompletedApril 11, 2024
April 1, 2024
Same day
February 2, 2023
April 10, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
assess of pragmatic skills
The patients is evaluated by means of a semi-directed interview
day 0
assess discourse skills
he patient is evaluated through two image description tasks
day 0
assess narrative skills
the patients is evaluated through the oral restitution of two heard texts.
day 0
Study Arms (1)
diagnostic
EXPERIMENTALall patients have the study test
Interventions
The aim of this study is to compare the effectiveness of a newly developed speech-language assessment tool for pragmatic and discourse skills for patients suffering from schizophrenia .
Eligibility Criteria
You may qualify if:
- Male or female between the ages of 18 and 60
- Patient with a diagnosis of schizophrenic spectrum disorder and other psychotic disorders meeting DSM V criteria
- Patient who has been clinically and treatment stable for at least three months
- Patient who can read and write French
- Patient who is a beneficiary of a social security plan or similar
- Patient with ability to sign free and informed consent
You may not qualify if:
- \- Patient hospitalized under restraint
- Patient under guardianship
- Patient who has stopped taking his or her treatment
- Patient who had a change in treatment in the period of less than three months prior to the pass
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu de Nice
Nice, 06003, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benoit Michel
Centre Hospitalier Universitaire de Nice
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2023
First Posted
February 24, 2023
Study Start
March 6, 2023
Primary Completion
March 6, 2023
Study Completion
February 13, 2024
Last Updated
April 11, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share